Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· June 2, 2026

Genius Group Completes First Investments for its AI Treasury with Pre-IPO exposure to SpaceX, Anthropic and OpenAI

View original at globenewswire.com
Genius Group Completes First Investments for its AI Treasury with Pre-IPO exposure to SpaceX, Anthropic and OpenAI First deployment includes approximately 16% exposure to Anthropic, 11% to SpaceX and 7% to OpenAI Company commences disciplined dollar-cost averaging into its AI Treasury Company provides further details o…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Singapore's territorial tax system has no general capital gains tax on equity and no withholding on capital appreciation, giving Genius Group an advantage as a treasury company

    60% confidence
  • Genius Group believes it is the only NYSE American-listed equity offering direct exposure to the combination of an operating AI education business, Bitcoin treasury, Jewel Bank stake, and pre-IPO frontier AI holdings via closed-end interval funds

    60% confidence
  • Genius Group's market capitalization of $45 million against total assets of $137 million represents a 0.3x price-to-total-assets multiple, compared to publicly listed AI holding companies trading at 2.0x-5.0x, suggesting a repricing opportunity once balance sheet value is fully recognized by the market

    60% confidence
  • Databricks surpasses $4.8B revenue run-rate, growing >55% year-over-year, and is raising over $4B in Series L at $134B valuation

    60% confidence
  • SpaceX plans to list on Nasdaq under ticker SPCX with a roadshow commencing June 8, 2026 and a reported valuation range of $1.7-2.0 trillion

    60% confidence
  • The next five years is expected to deliver unprecedented growth in exponential technologies, and what may be the largest IPO calendar in history, anchored by SpaceX, Anthropic, OpenAI, Figure AI, Databricks and Stripe. Genius Group intends to build a $800 million five-year treasury, beginning with an initial $100 million to participate as an investor in this unique moment in history for the benefit of our shareholders.

    60% confidence
  • In the past two weeks, SpaceX, OpenAI and Anthropic have all filed confidentially with the SEC for their respective IPOs. Genius Group shareholders are now positioned to benefit from the growth in our AI powered future, across all the leading Pre-IPO Frontier AI companies, from their shares in our Company.

    60% confidence
  • Anthropic announced the confidential filing of its draft S-1 with the SEC on June 1, 2026 at a US$965 billion post-money valuation following a $65 billion Series H, surpassing OpenAI as the most valuable private AI startup

    60% confidence
  • Approximately 46% of Genius Group's first $657,100 deployment maps through to the six leading frontier AI private companies (Anthropic, SpaceX, OpenAI, Databricks, Shield AI, Anduril). A further 16% maps to additional named pre-IPO positions, for a total named look-through of approximately 62%.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com